CytoSorbents Analyst Ratings
CytoSorbents Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
09/07/2023 | 67.36% | B. Riley Securities | → $4 | Reinstates | Buy → Buy |
08/02/2023 | 130.13% | HC Wainwright & Co. | → $5.5 | Reiterates | Buy → Buy |
05/03/2023 | 130.13% | HC Wainwright & Co. | → $5.5 | Reiterates | → Buy |
03/10/2023 | 130.13% | HC Wainwright & Co. | → $5.5 | Reiterates | → Buy |
11/04/2022 | 130.13% | HC Wainwright & Co. | $9 → $5.5 | Maintains | Buy |
05/04/2022 | 151.05% | B. Riley Securities | $7 → $6 | Maintains | Buy |
05/04/2022 | 276.57% | HC Wainwright & Co. | $13 → $9 | Maintains | Buy |
09/17/2020 | 527.62% | Jefferies | → $15 | Initiates Coverage On | → Buy |
09/01/2020 | 527.62% | SVB Leerink | → $15 | Initiates Coverage On | → Outperform |
05/06/2020 | 569.46% | B. Riley Securities | $12 → $16 | Maintains | Buy |
05/06/2020 | 485.77% | HC Wainwright & Co. | $13 → $14 | Maintains | Buy |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
09/07/2023 | 67.36% | B.莱利证券 | →$4 | 恢复 | 购买→购买 |
08/02/2023 | 130.13% | HC Wainwright公司 | →$5.5 | 重申 | 购买→购买 |
05/03/2023 | 130.13% | HC Wainwright公司 | →$5.5 | 重申 | →购买 |
03/10/2023 | 130.13% | HC Wainwright公司 | →$5.5 | 重申 | →购买 |
11/04/2022 | 130.13% | HC Wainwright公司 | $9→$5.5 | 维护 | 买 |
05/04/2022 | 151.05% | B.莱利证券 | $7→$6 | 维护 | 买 |
05/04/2022 | 276.57% | HC Wainwright公司 | $13→$9 | 维护 | 买 |
09/17/2020 | 527.62% | 杰富瑞 | →$15 | 开始承保 | →购买 |
09/01/2020 | 527.62% | SVB Leerink | →$15 | 开始承保 | →跑赢大盘 |
05/06/2020 | 569.46% | B.莱利证券 | $12→$16 | 维护 | 买 |
05/06/2020 | 485.77% | HC Wainwright公司 | $13→$14 | 维护 | 买 |
What is the target price for CytoSorbents (CTSO)?
CytoSorbents(CTSO)的目标价是多少?
The latest price target for CytoSorbents (NASDAQ: CTSO) was reported by B. Riley Securities on September 7, 2023. The analyst firm set a price target for $4.00 expecting CTSO to rise to within 12 months (a possible 67.36% upside). 5 analyst firms have reported ratings in the last year.
B·莱利证券于2023年9月7日报道了CytoSorbents(纳斯达克:CTSO)的最新目标价。这家分析公司将目标价定为4.00美元,预计CTSO将在12个月内上涨至67.36%。去年有5家分析公司公布了评级。
What is the most recent analyst rating for CytoSorbents (CTSO)?
对CytoSorbents(CTSO)的最新分析师评级是多少?
The latest analyst rating for CytoSorbents (NASDAQ: CTSO) was provided by B. Riley Securities, and CytoSorbents their buy rating.
分析师对CytoSorbents(纳斯达克代码:CTSO)的最新评级由B.莱利证券提供,CytoSorbents的评级为买入。
When is the next analyst rating going to be posted or updated for CytoSorbents (CTSO)?
CytoSorbents(CTSO)的下一次分析师评级将于何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CytoSorbents, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CytoSorbents was filed on September 7, 2023 so you should expect the next rating to be made available sometime around September 7, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括查看公开的财务报表,与CytoSorbents的高管和客户交谈,以及收听收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。CytoSorbents的上一次评级是在2023年9月7日提交的,所以你应该预计下一次评级将在2024年9月7日左右的某个时候公布。
Is the Analyst Rating CytoSorbents (CTSO) correct?
分析师对CytoSorbents(CTSO)的评级正确吗?
While ratings are subjective and will change, the latest CytoSorbents (CTSO) rating was a with a price target of $0.00 to $4.00. The current price CytoSorbents (CTSO) is trading at is $2.39, which is within the analyst's predicted range.
虽然评级是主观的,并将发生变化,但最新的CytoSorbents(CTSO)评级为A,目标价在0.00美元至4.00美元之间。目前CytoSorbents(CTSO)的交易价格为2.39美元,在分析师的预测范围内。